FOR IMMEDIATE RELEASE

Rho Federal Systems Division, Inc. Awarded Statistical and Data Coordinating Center Contract in BARDA Medical Countermeasures Clinical Studies Network

CRO will serve to standardize data collection, management, and analysis across BARDA-supported network studies.

Research Triangle Park, NC – November 9, 2020 – Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, announces the Rho Federal Systems Division, Inc. (RhoFED) was awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services to manage a Statistical and Data Coordinating Center (SDCC) for BARDA’s Medical Countermeasures Clinical Studies Network. Under the contract, RhoFED will be responsible for standardizing data collection, management, and analysis across BARDA-supported network studies.

As one of five full-service clinical CROs in BARDA’s original clinical studies network, RhoFED conducted three clinical trials to support BARDA’s national health security efforts and has a fourth influenza vaccine study in development.

“We are honored to continue our work with BARDA and aid in the search for safer and more effective medical countermeasures,” said Laura Helms Reece, CEO, Rho. “Rho brings more than 25 years of storied expertise in federal research support, and we are dedicated to bringing the best of Rho’s data management and biostatistics capabilities to our new responsibility as the SDCC.”

The SDCC will integrate with the new Biological Specimen and Investigational Product storage facility and four Clinical Trial Planning and Execution providers in support of BARDA’s mission, in partnership with medical countermeasure developers, by providing technical and regulatory assistance in development of vaccines, therapeutics, diagnostics, and medical devices to prevent or treat the medical consequences of chemical, biological, radiological, and nuclear threats; pandemic influenza; and emerging infectious diseases.  

As the SDCC manager, RhoFED will perform clinical trial data management, data quality control, data monitoring and statistical analyses, study design, Safety Monitoring Committee or Data and Safety Monitoring Board support, medical monitoring, data analysis, and reporting services. Included in RhoFED’s services is the capability of providing innovative trial design and system readiness for rapid trial start-up, which is critical to meeting the challenges of developing MCMs for emerging public health threats.

In addition, RhoFED will also provide a centralized clinical study record archive for long-term storage and, as needed, access to data mining capabilities via health care utilization databases through a strategic partnership.

RhoFED’s work as the SDCC will be funded with federal funds under BARDA Contract No. 75A50120D00015.

To learn more about RhoFED and its services, including clinical research and regulatory affairs support and consulting, please visit www.rhoworld.com.

About Rho

Rho, a privately held, contract research organization (CRO) located in Research Triangle Park, NC, provides a full range of clinical research services across the entire drug development process. For more than 35 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Facebook, LinkedIn and Twitter.

About Rho Federal Systems Division, Inc.

Rho Federal Systems Division, Inc. is a wholly owned subsidiary of Rho, Inc. Over the past 25 years, Rho has supported more than $500 million of federally funded research across multiple federal agencies and multiple therapeutic areas. In addition to serving as multiple statistical and data coordinating centers, Rho provides full-service support for Phase 1-4 clinical trials and observational studies and provides clinical research and regulatory affairs support services and consulting. To learn more about Rho, please visit www.rhoworld.com.

MEDIA CONTACT:

Melody Goforth (on behalf of Rho)

LARGEMOUTH COMMUNICATIONS

o: 919.459.6482 | m: 980.322.1210

melody@largemouthpr.com